Skip to main navigation menu Skip to main content Skip to site footer

Technical comment

Vol. 142 No. 1112 (2012)

Letter to the editor

  • Behzad Einollahi
  • Zohreh Rostami
Cite this as:
Swiss Med Wkly. 2012;142:w13530


  1. Hermann M, Enseleit F, Fisler AE, Flammer A, Lüscher TF, Noll G et al. Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. Swiss Med Wkly. 2011;141:w13149.
  2. Rostami Z, Einollahi B. Cyclosporine monitoring in organ transplantation: Do we need a new concept? Nephro-Urol Mon. 2011;3(2):97–8.
  3. Pape L, Lehnhardt A, Latta K, Ehrich JH, Offner G.. Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients. Clin Transplant. 2003;17(6):546–8.
  4. Gaspari F, Caruso R, Cattaneo D, Perico N, Remuzzi G. Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling? Transplant Proc. 2001;33(7-8):3117–9.
  5. Knight SR, Morris PJ. The clinical benefits of cyclosporine C2-level monitoring: a systematic review. Transplantation. 2007;83(12):1525–35.